A German-based global innovator in healthcare and medical technologies approached Freyr for Regulatory Intelligence (RI) services to launch their products in Canada, Turkey and Brazilian markets. The client’s portfolio had multiple innovative IVDs, which intended to detect viral respiratory infections, sexually transmitted infections and inflammatory markers for management of asthma. Owing to the scope of multiple devices in multiple countries, Freyr submitted a detailed device-specific RI report to the client, amidst various challenges of short turn-around-time, language barriers and less source of information in few countries.
Discover how Freyr navigated through the challenges and assisted the client to launch their multiple devices in multiple countries with a strategic approach. Download the proven case now.